Tygacil - 0008-4990-02 - (TIGECYCLINE)

Alphabetical Index


Drug Information of Tygacil

Product NDC: 0008-4990
Proprietary Name: Tygacil
Non Proprietary Name: TIGECYCLINE
Active Ingredient(s): 50    mg/5mL & nbsp;   TIGECYCLINE
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Tygacil

Product NDC: 0008-4990
Labeler Name: Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021821
Marketing Category: NDA
Start Marketing Date: 20050601

Package Information of Tygacil

Package NDC: 0008-4990-02
Package Description: 10 VIAL, SINGLE-USE in 1 CARTON (0008-4990-02) > 50 mL in 1 VIAL, SINGLE-USE (0008-4990-01)

NDC Information of Tygacil

NDC Code 0008-4990-02
Proprietary Name Tygacil
Package Description 10 VIAL, SINGLE-USE in 1 CARTON (0008-4990-02) > 50 mL in 1 VIAL, SINGLE-USE (0008-4990-01)
Product NDC 0008-4990
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name TIGECYCLINE
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20050601
Marketing Category Name NDA
Labeler Name Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc.
Substance Name TIGECYCLINE
Strength Number 50
Strength Unit mg/5mL
Pharmaceutical Classes Tetracycline-class Antibacterial [EPC],Tetracyclines [Chemical/Ingredient]

Complete Information of Tygacil


General Information